日韩精品久久无码中文字幕,青青草视频下载,一区二区在线观看电影院,一色屋精品视频在线观看

加入收藏 | 設(shè)為首頁(yè) | 聯(lián)系我們

產(chǎn)品搜索

產(chǎn)品分類(lèi)

聯(lián)系我們

聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com

產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73001BCR-ABL1/BaF3激酶細(xì)胞

BCR-ABL1/BaF3激酶細(xì)胞
名稱(chēng) BCR-ABL1/BaF3激酶細(xì)胞
型號(hào) CBP73001
報(bào)價(jià)
特點(diǎn) BCR-ABL1/BaF3激酶細(xì)胞,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO;
  • 詳細(xì)內(nèi)容

CBP73001

I. Introduction

Cell Line Name:

BCR-ABL1/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

II.Background

Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes.

ABL1 is a tyrosine kinase, and, in normal cells, it plays a role in cellular differentiation and regulation of the cell cycle. The BCR-ABL1 fusion gene creates a constitutively active tyrosine kinase, which leads to uncontrolled proliferation.

Imatinib is the first-generation ABL tyrosine kinase inhibitor, and it was approved by the FDA in 2001; label indications for CML include use in newly diagnosed adult and pediatric patients and in patients after failure of interferon-alpha therapy. While treatment responses to imatinib are often dramatic and lasting, 30–40% of patients will eventually need further treatment (Santos et al. 2011). In many but not all cases, this is due to the acquisition of point mutations in the tyrosine kinase domain of the BCR-ABL1 fusion gene, which renders the protein insensitive to the inhibitory effect of imatinib. This type of disease progression led to the development of second-line TKIs: dasatinib, nilotinib, and bosutinib. Dasatinib and bosutinib have the additional advantage of being inhibitors of SRC.

The second-generation TKIs, dasatinib, nilotinib, and bosutinib, are more potent than imatinib, and they were developed to treat cases of CML resistant to imatinib. Dasatinib and nilotinib are approved for use in CML in newly diagnosed adults, while dasatinib, nilotinib, and bosutinib are approved for use in adults with resistance or intolerance to prior therapy that included imatinib (FDA 2012). Soverini et al. (2011) made mutation-specific treatment decision recommendations that were adopted by NCCN (2012). Recommendations based on preclinical data are as follows: for T315I, HSCT or clinical trial; for V299L, T315A, and F317L/V/I/C, consider nilotinib rather than dasatinib; for Y253H, E255K/V, and F359V/C/I, consider dasatinib rather than nilotinib; and for all other mutations, consider high-dose imatinib, dasatinib, or nilotinib.

Ponatinib is a third-line TKI, developed specifically to address imatinib resistance due to the BCR-ABL1 T315I resistance mutation. Ponatinib is currently being investigated in phase III clinical trials.


III. Representative Data

1. WB of  BCR-ABL1/BaF3 expression



2. Sanger of BCR-ABL1/BaF3

Figure 2. BCR-ABL1/BaF3 Fusion

3. Anti-proliferation assay

Figure 3. CTG Proliferation Assay of BaF3 BCR-ABL1 WT Cells (C3).



如果你對(duì)CBP73001BCR-ABL1/BaF3激酶細(xì)胞感興趣,想了解更詳細(xì)的產(chǎn)品信息,填寫(xiě)下表直接與廠家聯(lián)系:


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說(shuō)明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫(xiě)阿拉伯?dāng)?shù)字),如:三加四=7

化工儀器網(wǎng)

推薦收藏該企業(yè)網(wǎng)站
亚洲十八禁网站| 国产成人精品久久久成人| 中国一级黄片老年人操逼| 大鸡吧插入学生妹的批中| 美女张开腿让男人桶出水| 放一个黄色黄色片大学生呢| 国产成人午夜福利av在线| 黄色特级久草片| 姐夫你鸡吧真大日本视频| 欧美精品一区二区久久精品| 美女露0的奶头无挡挡| 让男人坤巴翘的视频网站| 性少妇av免费在线观看| 粗大鸡巴操性感美女的逼| 乱子激情网AV| 国产未成女一区二区三区| 免费在线观看国产你懂的| 亚洲第一成年男人的天堂| 男生鸡巴操女人骚逼网站| c插屁股视频污| 在线亚洲中文精品第1页| 操浓毛美女破处自慰嫩逼| 日韩123免费看淫秽网| 韩国三级电影我的好妈妈| 狠狠躁夜夜躁人人爽人妻| 中文乱码35页在线观看| 一区二区在线观看电影院| A级毛片成人网站免费看| 久久久久久综合精品23| 精品蓝导航视频福利在线| 乳罩脱了喂男人吃奶视频| 欧美裸体男粗大1609| 亚洲欧美日产综合在线看| 中国黄色靠逼大片大黑逼| 亚洲一区丝袜美腿在线观看| 国产a久久久久久久久久| 啊啊啊啊在线免费看网站| 又色又爽又黄的视频女女| 8天堂精品乱码中文字幕| 韩国伦理片免费在线观看| 亚洲欧美国产国产第二页|